vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and Skyward Specialty Insurance Group, Inc. (SKWD). Click either name above to swap in a different company.
Skyward Specialty Insurance Group, Inc. is the larger business by last-quarter revenue ($385.6M vs $359.9M, roughly 1.1× AdvanSix Inc.). Skyward Specialty Insurance Group, Inc. runs the higher net margin — 11.2% vs -0.8%, a 12.0% gap on every dollar of revenue. On growth, Skyward Specialty Insurance Group, Inc. posted the faster year-over-year revenue change (26.7% vs 9.4%). Skyward Specialty Insurance Group, Inc. produced more free cash flow last quarter ($402.6M vs $36.1M). Over the past eight quarters, Skyward Specialty Insurance Group, Inc.'s revenue compounded faster (20.6% CAGR vs 3.4%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Skyward Specialty Insurance Group, Inc. is a specialty property and casualty insurance provider offering tailored coverage solutions including commercial auto, general liability, professional indemnity, and specialty property policies. It primarily serves small-to-medium enterprises and niche industry segments across the United States, focusing on underwriting complex, hard-to-place risks for underserved client groups.
ASIX vs SKWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $385.6M |
| Net Profit | $-2.8M | $43.2M |
| Gross Margin | 7.6% | — |
| Operating Margin | -0.7% | 14.2% |
| Net Margin | -0.8% | 11.2% |
| Revenue YoY | 9.4% | 26.7% |
| Net Profit YoY | -892.9% | 200.1% |
| EPS (diluted) | $-0.11 | $1.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $359.9M | $385.6M | ||
| Q3 25 | $374.5M | $382.5M | ||
| Q2 25 | $410.0M | $319.9M | ||
| Q1 25 | $377.8M | $328.5M | ||
| Q4 24 | $329.1M | $304.4M | ||
| Q3 24 | $398.2M | $300.9M | ||
| Q2 24 | $453.5M | $279.9M | ||
| Q1 24 | $336.8M | $265.0M |
| Q4 25 | $-2.8M | $43.2M | ||
| Q3 25 | $-2.6M | $45.9M | ||
| Q2 25 | $31.4M | $38.8M | ||
| Q1 25 | $23.3M | $42.1M | ||
| Q4 24 | $352.0K | $14.4M | ||
| Q3 24 | $22.3M | $36.7M | ||
| Q2 24 | $38.9M | $31.0M | ||
| Q1 24 | $-17.4M | $36.8M |
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | — | ||
| Q2 25 | 14.3% | — | ||
| Q1 25 | 14.2% | — | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | — | ||
| Q2 24 | 17.9% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | -0.7% | 14.2% | ||
| Q3 25 | -0.9% | 15.8% | ||
| Q2 25 | 7.7% | 15.6% | ||
| Q1 25 | 7.7% | 15.7% | ||
| Q4 24 | -3.9% | 6.1% | ||
| Q3 24 | 7.5% | 15.6% | ||
| Q2 24 | 11.5% | 14.4% | ||
| Q1 24 | -7.0% | 17.7% |
| Q4 25 | -0.8% | 11.2% | ||
| Q3 25 | -0.7% | 12.0% | ||
| Q2 25 | 7.7% | 12.1% | ||
| Q1 25 | 6.2% | 12.8% | ||
| Q4 24 | 0.1% | 4.7% | ||
| Q3 24 | 5.6% | 12.2% | ||
| Q2 24 | 8.6% | 11.1% | ||
| Q1 24 | -5.2% | 13.9% |
| Q4 25 | $-0.11 | $1.03 | ||
| Q3 25 | $-0.10 | $1.10 | ||
| Q2 25 | $1.15 | $0.93 | ||
| Q1 25 | $0.86 | $1.01 | ||
| Q4 24 | $0.02 | $0.33 | ||
| Q3 24 | $0.82 | $0.89 | ||
| Q2 24 | $1.43 | $0.75 | ||
| Q1 24 | $-0.65 | $0.90 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $168.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $1.0B |
| Total Assets | $1.7B | $4.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $19.8M | $168.5M | ||
| Q3 25 | $23.7M | $160.1M | ||
| Q2 25 | $18.4M | $136.6M | ||
| Q1 25 | $8.3M | $112.9M | ||
| Q4 24 | $19.6M | $121.6M | ||
| Q3 24 | $17.3M | $105.6M | ||
| Q2 24 | $12.1M | $73.0M | ||
| Q1 24 | $20.6M | $85.1M |
| Q4 25 | $815.2M | $1.0B | ||
| Q3 25 | $818.2M | $961.4M | ||
| Q2 25 | $823.7M | $899.9M | ||
| Q1 25 | $794.4M | $850.7M | ||
| Q4 24 | $774.6M | $794.0M | ||
| Q3 24 | $766.4M | $797.5M | ||
| Q2 24 | $746.6M | $723.6M | ||
| Q1 24 | $713.2M | $692.3M |
| Q4 25 | $1.7B | $4.8B | ||
| Q3 25 | $1.7B | $4.6B | ||
| Q2 25 | $1.6B | $4.3B | ||
| Q1 25 | $1.6B | $4.0B | ||
| Q4 24 | $1.6B | $3.7B | ||
| Q3 24 | $1.5B | $3.6B | ||
| Q2 24 | $1.5B | $3.4B | ||
| Q1 24 | $1.5B | $3.2B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $408.1M |
| Free Cash FlowOCF − Capex | $36.1M | $402.6M |
| FCF MarginFCF / Revenue | 10.0% | 104.4% |
| Capex IntensityCapex / Revenue | 7.7% | 1.4% |
| Cash ConversionOCF / Net Profit | — | 9.44× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $755.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $63.7M | $408.1M | ||
| Q3 25 | $26.6M | $171.4M | ||
| Q2 25 | $21.1M | $88.2M | ||
| Q1 25 | $11.4M | $96.8M | ||
| Q4 24 | $64.2M | $305.1M | ||
| Q3 24 | $57.3M | $168.0M | ||
| Q2 24 | $50.2M | $21.0M | ||
| Q1 24 | $-36.2M | $94.3M |
| Q4 25 | $36.1M | $402.6M | ||
| Q3 25 | $66.0K | $168.9M | ||
| Q2 25 | $-7.2M | $87.1M | ||
| Q1 25 | $-22.6M | $96.6M | ||
| Q4 24 | $29.8M | $300.9M | ||
| Q3 24 | $26.8M | $167.6M | ||
| Q2 24 | $16.7M | $18.4M | ||
| Q1 24 | $-71.6M | $94.0M |
| Q4 25 | 10.0% | 104.4% | ||
| Q3 25 | 0.0% | 44.2% | ||
| Q2 25 | -1.7% | 27.2% | ||
| Q1 25 | -6.0% | 29.4% | ||
| Q4 24 | 9.1% | 98.8% | ||
| Q3 24 | 6.7% | 55.7% | ||
| Q2 24 | 3.7% | 6.6% | ||
| Q1 24 | -21.3% | 35.5% |
| Q4 25 | 7.7% | 1.4% | ||
| Q3 25 | 7.1% | 0.6% | ||
| Q2 25 | 6.9% | 0.3% | ||
| Q1 25 | 9.0% | 0.1% | ||
| Q4 24 | 10.4% | 1.4% | ||
| Q3 24 | 7.7% | 0.1% | ||
| Q2 24 | 7.4% | 0.9% | ||
| Q1 24 | 10.5% | 0.1% |
| Q4 25 | — | 9.44× | ||
| Q3 25 | — | 3.73× | ||
| Q2 25 | 0.67× | 2.27× | ||
| Q1 25 | 0.49× | 2.30× | ||
| Q4 24 | 182.29× | 21.18× | ||
| Q3 24 | 2.57× | 4.58× | ||
| Q2 24 | 1.29× | 0.68× | ||
| Q1 24 | — | 2.56× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
SKWD
Segment breakdown not available.
